Price Action Don’t Lie: It Seems Amedisys Inc Will Go Down. Have Another Big Decline

Price Action Don't Lie: It Seems Amedisys Inc Will Go Down. Have Another Big Decline

The stock of Amedisys Inc (NASDAQ:AMED) is a huge mover today! About 982,547 shares traded hands or 267.31% up from the average. Amedisys Inc (NASDAQ:AMED) has declined 9.08% since April 4, 2016 and is downtrending. It has underperformed by 10.17% the S&P500.
The move comes after 7 months negative chart setup for the $1.28B company. It was reported on Nov, 4 by We have $35.85 PT which if reached, will make NASDAQ:AMED worth $76.80M less.

Amedisys Inc (NASDAQ:AMED) Ratings Coverage

Out of 9 analysts covering Amedisys Inc. (NASDAQ:AMED), 3 rate it a “Buy”, 0 “Sell”, while 6 “Hold”. This means 33% are positive. Amedisys Inc. has been the topic of 12 analyst reports since September 1, 2015 according to StockzIntelligence Inc. Mizuho upgraded the shares of AMED in a report on Tuesday, January 19 to “Buy” rating. On Tuesday, September 1 the stock rating was initiated by Wells Fargo with “Outperform”. The firm has “Market Perform” rating by Obsidian Research Group given on Tuesday, April 5. As per Friday, June 17, the company rating was initiated by Stephens. The rating was upgraded by Oppenheimer on Monday, February 8 to “Outperform”. Oppenheimer maintained the shares of AMED in a report on Thursday, March 10 with “Outperform” rating. The stock of Amedisys Inc (NASDAQ:AMED) has “Mkt Perform” rating given on Monday, January 11 by Raymond James. Mizuho downgraded it to “Neutral” rating and $45 target price in Wednesday, November 11 report. The company was maintained on Wednesday, January 13 by Robert W. Baird. RBC Capital Markets maintained the shares of AMED in a report on Friday, May 6 with “Sector Perform” rating.

According to Zacks Investment Research, “Amedisys, Inc. is a leading multi-regional provider of home health care nursing services. They operate home care nursing offices in southern and southeastern United States.”

Insitutional Activity: The institutional sentiment decreased to 0.88 in Q2 2016. Its down 0.21, from 1.09 in 2016Q1. The ratio dived, as 23 funds sold all Amedisys Inc shares owned while 55 reduced positions. 17 funds bought stakes while 52 increased positions. They now own 29.42 million shares or 0.50% more from 29.27 million shares in 2016Q1.
New York State Common Retirement Fund accumulated 78,945 shares or 0.01% of the stock. Timpani Cap Limited Liability has invested 1.89% of its portfolio in Amedisys Inc (NASDAQ:AMED). Moreover, Millennium Ltd Limited Liability Company has 0.01% invested in Amedisys Inc (NASDAQ:AMED) for 90,661 shares. The New York-based Blackrock has invested 0.01% in Amedisys Inc (NASDAQ:AMED). Blackrock Institutional Trust Na last reported 0.01% of its portfolio in the stock. Ameriprise Financial Incorporated holds 0.01% of its portfolio in Amedisys Inc (NASDAQ:AMED) for 174,275 shares. Kohlberg Kravis Roberts & Com Ltd Partnership has invested 2.57% of its portfolio in Amedisys Inc (NASDAQ:AMED). The United Kingdom-based Ahl Prtnrs Ltd Liability Partnership has invested 0.21% in Amedisys Inc (NASDAQ:AMED). Teachers Retirement Systems Of The State Of Kentucky has invested 0.01% of its portfolio in Amedisys Inc (NASDAQ:AMED). Aperio Group Ltd Liability Corp has 0% invested in the company for 11,562 shares. Marshall Wace Llp has invested 0.1% of its portfolio in Amedisys Inc (NASDAQ:AMED). Systematic Mgmt Ltd Partnership has invested 0.17% of its portfolio in Amedisys Inc (NASDAQ:AMED). Highland Capital Mngmt Lp reported 124,500 shares or 0.26% of all its holdings. Panagora Asset Inc last reported 0.03% of its portfolio in the stock. Gotham Asset Ltd Liability holds 0.03% of its portfolio in Amedisys Inc (NASDAQ:AMED) for 51,565 shares.

Insider Transactions: Since May 13, 2016, the stock had 1 insider buy, and 0 sales for $50,210 net activity. On Friday, May 13 PERKINS BRUCE D bought $50,210 worth of the stock or 1,000 shares.

Another recent and important Amedisys Inc (NASDAQ:AMED) news was published by which published an article titled: “Amedisys Brings In David B. Pearce As New Chief Compliance Officer” on June 17, 2016.

AMED Company Profile

Amedisys, Inc. (Amedisys), incorporated on June 28, 1994, is a well-known provider of home health and hospice services. The Firm offers home health services to the chronic, co-morbid, aging American population. The Firm operates through three divisions: home health, hospice and personal care. The Firm owns and operates approximately 330 Medicare-certified home healthcare centers, over 80 Medicare-certified hospice care centers and approximately nine personal-care care centers in over 34 states within the United States, the District of Columbia and Puerto Rico.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Related posts

Leave a Comment